Pharmacological conversion of recent-onset atrial fibrillation: A systematic review

Scandinavian Cardiovascular Journal

Volumn 47, Issue 1, 2013, Pages 2-10

  Heldal, Magnus ^a   Atar, Dan ^b  

^a Gardermoen Heart Centre   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Arrhythmia conversion; Atrial; Fibrillation; Pharmacological

Indexed keywords

AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; AZIMILIDE; BISOPROLOL; CARVEDILOL; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; METOPROLOL; PILSICAINIDE; PLACEBO; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; TIMOLOL; VERAPAMIL; VERNAKALANT;

DRUG INFORMATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINUS RHYTHM; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HEART CONDUCTION SYSTEM; HUMANS; PATIENT SELECTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872532647     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2012.740572     Document Type: Review

References (47)

1. Noc M, S tajer D, H orvat M. I ntravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fi brillation to sinus rhythm. Am J Cardiol. 1990 ; 65: 679-80.
2. Capucci A, L enzi T, B oriani G, T risolino G, B inetti N, Cavazza M, et al. Effectiveness of loading oral fl ecainide for converting recent-onset atrial fi brillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol. 1992 ; 70: 69-72.
3. Hou Z Y, C hang M S, C hen C Y, T u M S, L in S L, C hiang H T, Woosley RL. Acute treatment of recent-onset atrial fi brillation and fl utter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J. 1995 ; 16: 521-8.
4. Donovan KD, P ower BM, H ockings BE, D obb GJ, L ee KY. Intravenous fl ecainide versus amiodarone for recent-onset atrial fi brillation. Am J Cardiol. 1995 ; 75: 693-7.
5. Galve E, R ius T, B allester R, Artaza MA, Arnau JM, Garc í a-Dorado D, Soler-Soler J. Intravenous amiodarone in treatment of recent-onset atrial fi brillation: results of a randomized, controlled study. J Am Coll Cardiol. 1996 ; 27: 1079-82.
6. Boriani G, B iffi M, C apucci A, B otto G, B roffoni T, O ngari M, et al. Conversion of recent-onset atrial fi brillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol. 1998 ; 21: 2470-4.
7. Kochiadakis GE, Igoumenidis NE, Simantirakis EN, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE. Intravenous propafenone versus intravenous amiodarone in the management of atrial fi brillation of recent onset: A placebo-controlled study. Pacing Clin Electrophysiol. 1998 ; 21: 2475-9.
8. Cotter G, B latt A, K aluski E, M etzkor-Cotter E, K oren M, Litinski I, et al. Conversion of recent onset paroxysmal atrial fi brillation to normal sinus rhythm: The effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study. Eur Heart J. 1999 ; 20: 1833-42.
9. Peuhkurinen 9. K, N iemel ä M, - litalo A, L innaluoto M, Lilja M, Juvonen J. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fi brillation. Am J Cardiol. 2000 ; 85: 462-5.
10. Vardas PE, K ochiadakis GE, I goumenidis NE, T satsakis AM, Simantirakis EN, Chlouverakis GI. Amiodarone as a fi rstchoice drug for restoring sinus rhythm in patients with atrial fi brillation: A randomized, controlled study. Chest. 2000 ; 117: 1538-45.
11. Cybulski J, K u l akowski P, B udaj A, D anielewicz H, Maciejewicz J, Kawka-Urbanek T, Ceremuzy ń ski L. Intravenous amiodarone for cardioversion of recent-onset atrial fi brillation. Clin Cardiol. 2003 ; 26: 329-35.
12. Thomas SP, G uy D, W allace E, C rampton R, K ijvanit P, Eipper V, et al. Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fi brillation: A randomized, digoxin-controlled trial. Am Heart J. 2004; 147: E3.
13. Kochiadakis G E, I goumenidis NE, H amilos ME, Marketou ME, Chlouverakis GI, Vardas PE. A comparative study of the effi cacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recentonset atrial fi brillation. Am J Cardiol. 2007 ; 99: 1721-5.
14. Falk R H, K nowlton AA, B ernard S A, G otlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fi brillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med. 1987; 106: 503-6.
15. Jordaens L, T rouerbach J, C alle P, T avernier R, D erycke E, Vertongen P, et al. Conversion of atrial fi brillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J. 1997 ; 18: 643-8.
16. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Intravenous digoxin in acute atrial fi brillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. Eur Heart J. 1997 ; 18: 649-54.
17. Bianconi L, Mennuni M, PAFIT-3 Investigators. C omparison between propafenone and digoxin administered intravenously to patients with acute atrial fi brillation. Am J Cardiol. 1998 ; 82: 584-8.
18. Chiladakis J A, S tathopoulos C, D avlouros P, M anolis AS. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fi brillation. Int J Cardiol. 2001 ; 79: 287-91.
19. Boudonas G, L efkos N, E fthymiadis A P, S tyliadis IG, T sapas G. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Acta Cardiol. 1995 ; 50: 125-34.
20. Donovan K D, D obb G J, C oombs L J, L ee K Y, W eekes J N, Murdock CJ, Clarke GM. Reversion of recent-onset atrial fi brillation to sinus rhythm by intravenous fl ecainide. Am J Cardiol. 1991 ; 67: 137-41.
21. Reisinger J, G atterer E, H einze G, W iesinger K, Z eindlhofer E, Gattermeier M, et al. Prospective comparison of fl ecainide versus sotalol for immediate cardioversion of atrial fi brillation. Am J Cardiol. 1998 ; 81: 1450-4.
22. Stambler B S, W ood M A, E llenbogen K A, P erry K T, Wakefi eld LK, VanderLugt JT. Effi cacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial fl utter or fi brillation. Circulation. 1996 ; 94: 1613-21.
23. Reisinger J, G atterer E, L ang W, V anicek T, E isserer G, Bachleitner T, et al. Flecainide versus ibutilide for immediate cardioversion of atrial fi brillation of recent onset. Eur Heart J. 2004 ; 25: 1318-24.
24. Atarashi H, I noue H, H iejima K, H ayakawa H, T he P STAF Investigators. Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide. Am J Cardiol. 1996 ; 78: 694-7.
25. Kochiadakis GE, I goumenidis NE, S imantirakis E N, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE. Intravenous propafenone versus intravenous amiodarone in the management of atrial fi brillation of recent onset: A placebo-controlled study. Pacing Clin Electrophysiol. 1998; 21: 2475-9.
26. Madrid AH, M oro C, M ar í n-Huerta E, M estre JL, N ovo L, Costa A. Comparison of fl ecainide and procainamide in cardioversion of atrial fi brillation. Eur Heart J. 1993 ; 14: 1127-31.
27. Boriani G, C apucci A, L enzi T, S anguinetti M, M agnani B. Propafenone for conversion of recent-onset atrial fi brillation. A controlled comparison between oral loading dose and intravenous administration. Chest. 1995 ; 108: 355-8.
28. Fresco C, P roclemer A, P avan A, B uia G, V icentini A, Pavan D, Morgera T. Intravenous propafenone in paroxysmal atrial fi brillation: A randomized, placebo-controlled, double-blind, multicenter clinical trial. Clin Cardiol. 1996 ; 19: 409-12.
29. Bellandi F, D abizzi R P, C antini F, N atale M D, N iccoli L. Intravenous propafenone: effi cacy and safety in the conversion to sinus rhythm of recent onset atrial fi brillation-a single-blind placebo-controlled study. Cardiovasc Drugs Ther. 1996 ; 10: 153-7.
30. Botto GL, C apucci A, B onini W, B oriani G, B roffoni T, Barone P, et al. Conversion of recent onset atrial fi brillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol. 1997 ; 58: 55-61.
31. Boriani G, B iffi M, C apucci A, B otto GL, B roffoni T, Rubino I, et al. Oral propafenone to convert recent-onset atrial fi brillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med. 1997 ; 126: 621-5.
32. Azpitarte J, A lvarez M, B aú n O, G arc í a R, M oreno E, Mart í n F, et al. Value of single oral loading dose of propafenone in converting recent-onset atrial fi brillation. Results of a randomized, double-blind, controlled study. Eur Heart J. 1997 ; 18: 1649-54.
33. Ganau G, L enzi T. I ntravenous propafenone for converting recent onset atrial fi brillation in emergency departments: A randomized placebo-controlled multicenter trial. J Emerg Med. 1998 ; 16: 383-7.
34. Botto GL, B onini W, B roffoni T, E spureo M, C appelletti G, Lombardi R, et al. Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fi brillation. Pacing Clin Electrophysiol. 1998 ; 21: 2480-4.
35. Capucci A, B oriani G, R ubino I, D ella Casa S, Sanguinetti M, Magnani B. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fi brillation to sinus rhythm. Int J Cardiol. 1994 ; 43: 305-13.
36. Capucci A, V illani G Q, A schieri D, P iepoli M. S afety of oral propafenone in the conversion of recent onset atrial fi brillation to sinus rhythm: A prospective parallel placebocontrolled multicentre study. Int J Cardiol. 1999 ; 68: 187-96. Erratum in: Int J Cardiol 1999;70:213.
37. Halinen MO, H uttunen M, P aakkinen S, T arssanen L. C omparison of sotalol with digoxin-quinidine for conversion of acute atrial fi brillation to sinus rhythm. Am J Cardiol. 1995 ; 76: 495-8.
38. Sung RJ, T an HL, K aragounis L, H anyok JJ, F alk R, P latia E, et al. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fi brillation and fl utter: A multicenter, randomized, double-blind, placebo-controlled study. Am Heart J. 1995 ; 129: 739-48.
39. Suttorp MJ, K ingma JH, L ie -A - Huen L, M ast EG. Intravenous fl ecainide versus verapamil for acute conversion of paroxysmal atrial fi brillation or fl utter to sinus rhythm. Am J Cardiol. 1989 ; 63: 693-6.
40. Kondili. A, K astrati A, P opa Y. C omparative evaluation of verapamil, fl ecainide and propafenone for the acute conversion of atrial fi brillation to sinus rhythm. Wien Klin Wochenschr. 1990 ; 102: 510-3.
41. Platia E V, M ichelson E L, P orterfi eld J K, D as G. E smolol versus verapamil in the acute treatment of atrial fi brillation or atrial fl utter. Am J Cardiol. 1989 ; 63: 925-9.
42. Roy D, Rowe B H, Stiell I G, Coutu B, I p J H, Phaneuf D, et al. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fi brillation. J Am Coll Cardiol. 2004 ; 44: 2355-61.
43. Roy D, P ratt C M, T orp-Pedersen C, W yse D G, T oft E, Juul-Moller S, et al. Vernakalant hydrochloride for rapid conversion of atrial fi brillation: A phase 3, randomized, placebocontrolled trial. Circulation. 2008 ; 117: 1518-25.
44. Pratt C M, R oy D, T orp-Pedersen C, W yse D G, T oft E, J uul-Moller S, et al. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fi brillation. Am J Cardiol. 2010 ; 106: 1277-83.
45. Camm A J, C apucci A, H ohnloser S H, Torp-Pedersen C, Van Gelder IC, Mangal B, et al. A randomized activecontrolled study comparing the effi cacy and safety of vernakalant to amiodarone in recent-onset atrial fi brillation. J Am Coll Cardiol. 2011 ; 57: 313-21.
46. Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, et al. Outpatient treatment of recent-onset atrial fi brillation with the " pill-in-the-pocket " approach. N Engl J Med. 2004 ; 351: 2384-91.
47. Alboni P, B otto GL, B oriani G, R usso G, P acchioni F, Iori M, et al. Intravenous administration of fl ecainide or propafenone in patients with recent-onset atrial fi brillation does not predict adverse effects during ' pill-in-the-pocket ' treatment. Heart. 2010 ; 96: 546-9.